Vertex Pharmaceuticals Incorporated (VRTX) short interest & options flow
NASDAQOptions traders have grown modestly more cautious ahead of VRTX's November 2 results, even as short sellers continue to trim their positions. The put/call ratio has drifted up to 0.97, about 1.2 standard deviations above its 20-day average of 0.92. That places it well above where it spent most of September, though still far from the 52-week high of 1.27. The move is mild rather…
- Market cap
- $134.53B
- Next earnings
- 8 Feb 2027
Key data as of 4 Nov 2026

VRTX news and analysis
RSSNo long-form analysis yet for VRTX. Pulse alerts and the live data picture are available on ORTEX.
Open VRTX on ORTEX →Want the live picture for VRTX?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for VRTX — free to start on ORTEX.
Sign up for free →Open VRTX on ORTEX